"We are confident that the FTC thoroughly and carefully reviewed the competitive impact of the merger between Express Scripts and Medco. We believe that maintaining competition in this industry is essential to keeping drug prices down and ensuring that consumer's prescription drug benefits are affordable. We are also aware of the vital role of local, community pharmacists in serving consumers, and will continue to monitor this industry to ensure that consumers continue to have access to their local pharmacists to serve their prescription drug needs. We expect the FTC to carefully monitor the market to ensure that consumers are not harmed by loss of community pharmacies."